Page 1 of Clinical Trials for Complete Remission, 2638 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Completed
Comparison of the Classical Healing Concept With the Complete Remission Concept After Treatment With Pantoprazole in Adult Patients With Erosive GERD (Gastroesophageal Reflux Disease) (BY1023/M3-342)
Last Updated: May 4, 2012
Condition(s): Gastroesophageal Reflux Disease
2
Not yet recruiting
CNDO-109-AANK for AML in First Complete Remission (CR1)
Last Updated: January 25, 2012
Condition(s): Acute Myeloid Leukemia
3
Completed
Efficacy of Pantoprazole in Patients Older Than 18 Years Who Have Symptoms of Acid Reflux (Gastroesophageal Reflux Disease) (BY1023/M3-339)
Last Updated: May 4, 2012
Condition(s): Gastroesophageal Reflux
4
Recruiting
Autologous Peripheral Blood Stem Cell Transplantation With In Vivo Purging as an Alternate Stem Cell Transplantation Program for Pts w/AML in 1st & 2nd Complete Remission w/no HLA Matched Related Donor
Last Updated: December 11, 2011
Condition(s): Leukemia, Monocytic, Acute
5
Completed
Autologous Bone Marrow Transplant for Children With Acute Myelogenous Leukemia (AML) in First Complete Remission
Last Updated: April 25, 2008
Condition(s): Acute Myeloid Leukemia
6
Recruiting
HCT Versus CT in Elderly AML
Last Updated: December 6, 2011
Condition(s): Acute Myeloid Leukemia
7
Completed
A Study of Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) As Maintenance Therapy in Patients With Ovarian Cancer in a Second or Third Complete Remission
Last Updated: April 2, 2012
Condition(s): Ovarian Cancer
8
Active, not recruiting
Study of the BiovaxId Tumor Derived Idiotype Vaccine in Patients With Follicular Lymphoma
Last Updated: February 1, 2012
Condition(s): Non-Hodgkins Lymphoma
9
Completed
Vaccine Therapy in Treating Patients With Acute Myeloid Leukemia in Complete Remission
Last Updated: May 12, 2011
Condition(s): Leukemia
10
Recruiting
Allogeneic GM-CSF Vaccine and Lenalidomide in Treating Myeloma Patients With Near Complete Remission
Last Updated: March 7, 2012
Condition(s): Multiple Myeloma
11
Completed
Tipifarnib in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome in Complete Remission
Last Updated: March 9, 2010
Condition(s): Leukemia; Myelodysplastic Syndromes
12
Recruiting
Cvac as Maintenance Treatment in Patients With EOC in Complete Remission Following First-Line Chemotherapy
Last Updated: May 2, 2012
Condition(s): Epithelial Ovarian Cancer
13
Recruiting
Fludarabine and Busulfan Followed by Allogeneic Stem Cell Transplant in Treating Older Patients With Acute Myeloid Leukemia in First Complete Remission
Last Updated: April 2, 2011
Condition(s): Leukemia
14
Recruiting
OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete Remission
Last Updated: May 22, 2012
Condition(s): Fallopian Tube Cancer; Ovarian Cancer; Primary Peritoneal Cavity Cancer
15
Active, not recruiting
Validation of a Predictive Model After Complete Response in Rectal Cancer
Last Updated: April 19, 2012
Condition(s): Rectal Cancer
16
Recruiting
Azacitidine as Maintenance Therapy in Treating Older Patients With Acute Myeloid Leukemia in Complete Remission After Chemotherapy
Last Updated: September 18, 2010
Condition(s): Leukemia
17
Active, not recruiting
Green Tea Intake for the Maintenance of Complete Remission in Women With Advanced Ovarian Carcinoma
Last Updated: February 23, 2012
Condition(s): Ovarian Carcinoma
18
Active, not recruiting
Study Comparing the Zevalin Regimen With no Further Treatment in DLBCL Patients Who Are in Complete Remission After CHOP-R
Last Updated: October 22, 2008
Condition(s): Lymphoma, Large Cell, Diffuse
19
Recruiting
Study of Zevalin Versus Observation in Patients at Least 60 Yrs Old With Newly Diagnosed Diffuse Large B-cell Lymphoma in PET-negative Complete Remission After R-CHOP or R-CHOP-like Therapy
Last Updated: April 25, 2012
Condition(s): Diffuse Large B-cell Lymphoma; Follicle Center Lymphoma
20
Completed
Treatment With [90]Y-Ibritumomab Tiuxetan Versus no Treatment in Patients With Follicular Non Hodgkin Lymphoma (Stage III or IV) Having Achieved a Partial or Complete Remission After First Line Chemotherapy
Last Updated: November 26, 2008
Condition(s): Lymphoma, Non-Hodgkin

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Complete+Remission

Page 1 of Clinical Trials for Complete Remission, 2638 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About